Week25, 2024
1. Influenza activity remains low nationwide, with 1.1% of respiratory specimens testing positive for influenza in clinical labs.
2. Of the 352 clinical lab positive specimens, 80.4% were Influenza A and 19.6% were Influenza B.
3. Public health labs reported 101 positive specimens, with 81.2% Influenza A (62.5% H3N2, 37.5% H1N1) and 18.8% Influenza B (100% Victoria lineage).
4. Outpatient visits for respiratory illness accounted for 1.5%, below the baseline, with no jurisdictions reporting moderate or higher activity levels.
5. Weekly hospitalization rate for influenza was 0.2 per 100,000 population, showing very low activity.
6. Deaths attributed to influenza accounted for 0.1% of total deaths, while three pediatric influenza-associated deaths were reported this week, bringing the season's total to 181.
7. Two human infections with novel Influenza A(H1N2)v were reported in Pennsylvania, linked to swine exposure, with no evidence of sustained human-to-human transmission.
8. Influenza A (H1N1)pdm09, A(H3N2), and B/Victoria viruses co-circulate, with high antigenic similarity to vaccine strains and minimal antiviral resistance observed.
9. Vaccination trends were not detailed in this report but importance was emphasized for high-risk groups.
10. Future flu activity remains uncertain, as multiple respiratory viruses, including RSV and SARS-CoV-2, contribute to respiratory illnesses in varying proportions.